An Open-Label, Randomized, Crossover Adaptive Design Study to Assess the Effect of Food on the Pharmacokinetics of BMS-955176 Administered as a Micronized Crystalline Tablet in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2017
At a glance
- Drugs GSK 3532795 (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 26 Jul 2016 Status changed from recruiting to completed.
- 10 May 2016 Planned End Date changed from 1 May 2016 to 1 Jul 2016.
- 10 May 2016 Planned primary completion date changed from 1 May 2016 to 1 Jul 2016.